Ferric Carboxymaltose in HF with Iron Deficiency | NEJM
17
0
2024-1-5 16:36
Semaglutide in Heart Failure with Obesity | NEJM
Dennis’ Patient Story - Living with HeartMate 3 LVAD for Heart Failure
Is the Price Right? Heart Failure Drug Choices
Managing Heart Failure - Creating a Plan for Testing, Medication and Nutrition
心電図がない時のＤＣＭ
Upping the Pace in Acute Decompensated Heart Failure Therapy
Integrated Heart Failure Patient Management EP and HF Perspective
325症例目（M弁T弁形成術後）
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
In patients with heart failure, a reduced ejection fraction, and iron deficiency, intravenous ferric carboxymaltose improves quality of life and functional capacity; clinical outcomes are unclear.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/44rzIe4
Comments 0
Please to post a comment~
Loading...
Related Suggestion